GO:0015818 isoleucine transport: Nutrient Uptake, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015818 (isoleucine transport) describes the directed movement of the branched-chain amino acid isoleucine across cellular membranes via transporters or pores.
• Isoleucine transport is essential for protein synthesis and metabolic signaling, and its dysregulation is linked to metabolic and infectious diseases [1,3].
• Multiple transport systems with overlapping specificity for isoleucine, leucine, and valine exist in bacteria such as Escherichia coli [2,4].
• In humans, isoleucine transport is critical for erythrocyte infection by Plasmodium falciparum, highlighting its role in host-pathogen interactions.
• Emerging evidence links isoleucine and its transport to intestinal barrier dysfunction and inflammatory responses via NF-κB signaling.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of isoleucine transporter function in health and disease [1,3,5].
Description
Isoleucine is an essential branched-chain amino acid (BCAA) that must be obtained from the diet or environment and transported into cells to support protein synthesis and metabolic regulation. The Gene Ontology term GO:0015818, isoleucine transport, defines the directed movement of isoleucine into, out of, or within a cell, or between cells, by means of a transporter or pore. This process is fundamental to nitrogen and energy homeostasis and is conserved from bacteria to humans [2,4]. Research on isoleucine transport spans microbiology, parasitology, plant biology, and human metabolism. In bacteria, multiple transport systems with overlapping specificity for isoleucine, leucine, and valine have been genetically characterized [2,4]. In humans, isoleucine transport is essential for erythrocyte infection by the malaria parasite Plasmodium falciparum. More recently, isoleucine has been implicated in metabolic diseases and intestinal inflammation, underscoring the need to understand its transport mechanisms [1,5]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of isoleucine transport, its molecular players, regulatory context, and experimental approaches for studying it.
isoleucine transport At A Glance
| GO ID | GO:0015818 |
|---|---|
| GO term | isoleucine transport |
| Ontology | biological_process |
| Synonym | L-isoleucine transport |
| Major function | Directed movement of isoleucine across membranes via transporters or pores |
| Related amino acids | Leucine and valine (shared transport systems) [2,4] |
| Key organisms | Escherichia coli, Corynebacterium glutamicum, Plasmodium falciparum, humans [2,3,6] |
| Disease relevance | Metabolic disorders, malaria, intestinal inflammation [1,3,5] |
What Is GO:0015818?
Isoleucine transport (GO:0015818) is the biological process by which isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid, is moved across cellular membranes. This directed movement can occur into, out of, or within a cell, or between cells, and is mediated by specific transporter proteins or pores. The process is also known as L-isoleucine transport and is essential for supplying cells with this essential amino acid for protein synthesis and metabolic signaling [1,2,4].
Why Is isoleucine transport Important in Cell Biology?
Isoleucine transport is critical because isoleucine is an essential BCAA that cannot be synthesized by humans and must be imported to sustain protein synthesis and metabolic signaling. Defects or alterations in transport can disrupt cellular amino acid homeostasis, impacting processes ranging from bacterial growth to human immunity and metabolism [2,4]. In pathogens like Plasmodium falciparum, isoleucine transport is a potential drug target. In metabolic diseases, isoleucine and its transport influence insulin resistance and intestinal inflammation [1,5]. Thus, understanding isoleucine transport is vital for basic biology and therapeutic development.
• Essential for protein synthesis: isoleucine is a building block for proteins and must be transported into cells.
• Metabolic signaling: isoleucine and its transport influence mTOR signaling and insulin sensitivity.
• Host-pathogen interactions: Plasmodium falciparum relies on isoleucine transport for erythrocyte infection.
• Intestinal health: isoleucine transport affects barrier function and NF-κB-mediated inflammation.
• Bacterial physiology: multiple transport systems ensure isoleucine uptake for growth and adaptation [2,4].
• Industrial biotechnology: transport engineering improves L-isoleucine production in Corynebacterium glutamicum.
• Plant biology: jasmonoyl-isoleucine transport is involved in wound signaling.
• Regulatory insights: transport and biosynthesis are separately regulated in bacteria.
• Disease biomarkers: altered isoleucine levels are associated with metabolic disorders.
• Therapeutic target: transporters could be targeted for anti-infective or metabolic therapies [3,5].
What Happens During isoleucine transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs isoleucine.
Isoleucine transporters exhibit specificity for isoleucine, often sharing affinity with leucine and valine due to structural similarity [2,4]. In Escherichia coli, genetic studies identified distinct transport systems for these BCAAs, with mutations affecting uptake. The binding of isoleucine to the transporter triggers conformational changes that initiate translocation.
Translocation Across the Membrane
In simple terms: The transporter moves isoleucine through the membrane.
Once bound, the transporter undergoes conformational changes to shuttle isoleucine across the lipid bilayer. This process can be active or passive, depending on the system. In Corynebacterium glutamicum, transport proteins influence L-isoleucine production, indicating active export and import mechanisms. In Plasmodium falciparum-infected erythrocytes, isoleucine transport is essential for parasite survival, suggesting a specific uptake pathway.
Release and Intracellular Utilization
In simple terms: Isoleucine is released inside the cell for use.
After translocation, isoleucine is released into the cytoplasm, where it can be incorporated into proteins or used in metabolic pathways. In plants, jasmonoyl-isoleucine is transported distally upon wounding, indicating release and systemic signaling. In bacteria, intracellular isoleucine feeds into biosynthetic and regulatory networks.
Regulation of Transport Activity
In simple terms: The cell controls how much isoleucine is transported.
Transport activity is regulated separately from biosynthesis. In bacteria, mutations affecting transport systems alter isoleucine uptake without affecting synthesis, demonstrating independent regulation. In humans, isoleucine transport may be modulated by metabolic status and inflammatory signals, as seen in periodontitis-associated metabolite effects on intestinal barrier.
Key Genes Involved in GO:0015818 isoleucine transport
The following genes and proteins are experimentally implicated in isoleucine transport across various organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| livJ | Leucine/isoleucine/valine-binding protein in E. coli | Periplasmic binding protein for BCAA transport |
| livK | Leucine-specific binding protein in E. coli | Component of high-affinity BCAA transport system |
| livH | Membrane component of BCAA transport system | Forms channel for substrate translocation |
| livM | Membrane component of BCAA transport system | Essential for transport activity |
| livG | ATP-binding component of BCAA transport system | Provides energy for active transport |
| brnQ | Low-affinity BCAA transporter in E. coli | Alternative uptake system for isoleucine |
| Cglu_ transporters | Isoleucine export/import in C. glutamicum | Engineered for improved L-isoleucine production |
| PfHT1 | Hexose transporter in P. falciparum | Indirectly supports isoleucine uptake for parasite growth |
| SLC7A5 | L-type amino acid transporter 1 (LAT1) in humans | Transports BCAAs including isoleucine |
| SLC3A2 | 4F2hc heavy chain, partners with LAT1 | Forms heterodimeric transporter for BCAA uptake |
| SLC1A5 | Alanine-serine-cysteine transporter 2 (ASCT2) | Contributes to BCAA transport in some tissues |
| SLC38A2 | Sodium-coupled neutral amino acid transporter 2 | Mediates isoleucine uptake in mammalian cells |
| JAR1 | Jasmonoyl-isoleucine synthetase in plants | Produces JA-Ile for transport and signaling |
| ABC transporters | ATP-binding cassette transporters in bacteria | Facilitate isoleucine uptake |
| NF-κB pathway genes | Inflammatory signaling downstream of isoleucine | Mediate intestinal inflammation upon isoleucine exposure |
How Is isoleucine transport Regulated?
Isoleucine transport is regulated at multiple levels. In bacteria, transport systems are subject to independent genetic regulation from biosynthetic pathways, as shown by mutations that affect uptake without altering synthesis. In Corynebacterium glutamicum, transport protein expression is modulated to optimize L-isoleucine production, indicating transcriptional control. In mammals, isoleucine transport can be influenced by metabolic hormones and inflammatory signals; for instance, periodontitis-associated isoleucine impairs intestinal barrier function via NF-κB signaling, suggesting that transport activity may be modulated during inflammation. Additionally, the mTOR pathway senses intracellular isoleucine levels, creating a feedback loop that may indirectly regulate transport.
isoleucine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A5 | Metabolic syndrome, insulin resistance | Knockout mice, cell lines |
| PfHT1 | Malaria | Parasite knockout, erythrocyte infection assays |
| NF-κB pathway | Intestinal inflammation | Intestinal epithelial cell knockout |
| livJ | Bacterial growth defects | E. coli knockout |
| brnQ | Bacterial transport deficiency | E. coli knockout |
Metabolic Disorders and Insulin Resistance
Elevated circulating isoleucine is associated with insulin resistance and metabolic syndrome. Studies in mice show that reducing dietary isoleucine improves metabolic health, and transport mechanisms likely influence tissue-specific isoleucine levels. Thus, isoleucine transporters could be targets for metabolic disease interventions.
Malaria Pathogenesis
Plasmodium falciparum, the malaria parasite, relies on isoleucine transport from host erythrocytes for its survival. Inhibiting isoleucine uptake could starve the parasite, making transporters potential antimalarial drug targets.
Intestinal Inflammation
Periodontitis-associated metabolite isoleucine impairs intestinal barrier function and exacerbates inflammatory responses via NF-κB signaling. This suggests that isoleucine transport into intestinal cells may contribute to inflammatory bowel diseases.
From isoleucine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of SLC7A5 affect isoleucine uptake? | SLC7A5 knockout cell line |
| Does point mutation in livJ alter substrate specificity? | livJ point-mutant E. coli |
| Can knock-in of human SLC7A5 rescue transport in yeast? | Yeast knock-in model |
| Does overexpression of brnQ increase isoleucine import? | E. coli overexpression strain |
| Does tagged knock-in of SLC3A2 allow localization studies? | Tagged knock-in cell line |
| Does knockout of JAR1 affect jasmonoyl-isoleucine transport? | Arabidopsis knockout |
How to Study the isoleucine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Bacterial and parasite transport [2,3] |
| CRISPR knockout screen | Gene essentiality for transport | Human transporter discovery |
| Metabolomics | Intracellular/extracellular isoleucine levels | Metabolic disease studies [1,5] |
| Fluorescence microscopy | Transporter localization | Tagged knock-in cell lines |
| Growth assays | Ability to utilize isoleucine | Bacterial mutant characterization [2,4] |
| RNA-seq | Expression of transport genes | Regulation studies |
| Proteomics | Transporter protein abundance | Membrane protein analysis |
| Genetic complementation | Functional rescue by transporter | Yeast or E. coli models |
Genetic Screens and Knockout Studies
Classical genetic screens in Escherichia coli identified multiple transport systems for isoleucine, leucine, and valine through mutations that alter uptake [2,4]. These studies used growth assays and radioactive uptake to characterize transporters. Modern CRISPR knockout screens can systematically identify human isoleucine transporters.
Transport Assays
Radiolabeled isoleucine uptake assays measure transport activity in cells or membrane vesicles. Such assays were used to demonstrate isoleucine transport in Plasmodium falciparum-infected erythrocytes and to characterize bacterial transport systems.
Metabolomics and Flux Analysis
Metabolomic profiling quantifies intracellular and extracellular isoleucine levels, revealing transport efficiency. Studies linking isoleucine to metabolic health used metabolomics to show that reducing isoleucine improves metabolic parameters. In intestinal inflammation, metabolomics identified isoleucine as a periodontitis-associated metabolite.
Imaging and Localization
Fluorescent tagging of transporters allows visualization of their subcellular localization and trafficking. For example, tagged knock-in of SLC3A2 can reveal its membrane distribution. In plants, jasmonoyl-isoleucine transport was tracked using labeled compounds.
How CRISPR Can Be Used to Study GO:0015818 isoleucine transport
Knockout
CRISPR knockout of candidate isoleucine transporter genes (e.g., SLC7A5, SLC3A2) in human cell lines can abolish isoleucine uptake, leading to growth arrest unless isoleucine is supplemented. Such models are valuable for confirming transporter essentiality and for identifying compensatory pathways.
Point Mutation
Introducing point mutations in transporter genes (e.g., livJ in E. coli) can alter substrate specificity or transport kinetics. CRISPR point mutation in human SLC7A5 can mimic naturally occurring variants and reveal structure-function relationships.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC3A2) allows real-time imaging of localization and trafficking. Knock-in of human transporters into model organisms (e.g., yeast) can rescue transport defects and validate function.
Overexpression
CRISPR activation or cDNA overexpression of isoleucine transporters (e.g., brnQ in E. coli) increases uptake capacity and can be used to study transport kinetics or to engineer strains for amino acid production.
How EDITGENE Supports isoleucine transport Research
Researchers studying isoleucine transport-related genes often need to determine whether a candidate gene is causally involved in uptake, metabolism, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling functional validation of transporters and their regulators.
Contact EDITGENE today to design your custom CRISPR model for isoleucine transport research.
Frequently Asked Questions About isoleucine transport
What is isoleucine transport?
Isoleucine transport (GO:0015818) is the directed movement of the essential amino acid isoleucine across cellular membranes via transporters or pores.
What genes are involved in isoleucine transport?
Key genes include SLC7A5, SLC3A2, SLC1A5, SLC38A2 in humans, and livJ, livK, brnQ in bacteria [1,2,4].
Why is isoleucine transport important?
It supplies cells with isoleucine for protein synthesis and metabolic signaling; defects are linked to metabolic diseases and infections [1,3,5].
How is isoleucine transport regulated?
Regulation occurs at transcriptional and post-transcriptional levels, and is influenced by metabolic status and inflammation [5,8].
What diseases are associated with isoleucine transport?
Metabolic syndrome, malaria, and intestinal inflammation have been linked to altered isoleucine transport [1,3,5].
What methods study isoleucine transport?
Radiolabeled uptake assays, CRISPR screens, metabolomics, and imaging are commonly used [1,2,3,7].
Can CRISPR knockout isoleucine transporters?
Yes, CRISPR knockout of SLC7A5 or SLC3A2 abolishes isoleucine uptake and impairs cell growth.
Is isoleucine transport conserved across species?
Yes, transport systems exist from bacteria to humans, though the specific proteins differ [2,3,4].
What is the role of isoleucine transport in malaria?
Plasmodium falciparum relies on isoleucine transport from host erythrocytes for survival, making it a drug target.
How does isoleucine transport affect intestinal health?
Isoleucine impairs intestinal barrier function via NF-κB signaling, suggesting transport influences inflammation.
Conclusion
Isoleucine transport (GO:0015818) is a fundamental biological process that ensures cellular supply of an essential amino acid. Its molecular players range from bacterial permeases to human SLC transporters, and its dysregulation is implicated in metabolic disorders, malaria, and intestinal inflammation [1,3,5]. Understanding the mechanisms and regulation of isoleucine transport offers opportunities for therapeutic intervention and biotechnological applications. By leveraging CRISPR-based models and advanced omics, researchers can dissect the precise roles of individual transporters and their regulatory networks. EDITGENE provides the tools and expertise to accelerate such discoveries.
References
- 1. Yu D et al.. 2021. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine.. Cell Metab 33(5):905-922.e6 PMID: 33887198
- 2. Guardiola J et al.. 1974. Mutations affecting the different transport systems for isoleucine, leucine, and valine in Escherichia coli K-12.. J Bacteriol 117(2):393-405 PMID: 4590465
- 3. Martin RE et al.. 2007. Transport of the essential nutrient isoleucine in human erythrocytes infected with the malaria parasite Plasmodium falciparum.. Blood 109(5):2217-24 PMID: 17047158
- 4. Guardiola J et al.. 1974. Multiplicity of isoleucine, leucine, and valine transport systems in Escherichia coli K-12.. J Bacteriol 117(2):382-92 PMID: 4590464
- 5. Wang X et al.. 2025. Periodontitis-associated metabolite isoleucine impairs intestinal barrier function and exacerbates intestinal inflammatory response by NF-κB signaling.. Front Cell Infect Microbiol 15:1684362 PMID: 41394102
- 6. Xie X et al.. 2012. Effect of transport proteins on L-isoleucine production with the L-isoleucine-producing strain Corynebacterium glutamicum YILW.. J Ind Microbiol Biotechnol 39(10):1549-56 PMID: 22733295
- 7. Sato C et al.. 2011. Distal transport of exogenously applied jasmonoyl-isoleucine with wounding stress.. Plant Cell Physiol 52(3):509-17 PMID: 21266461
- 8. Quay SC et al.. 1975. Separate regulation of transport and biosynthesis of leucine, isoleucine, and valine in bacteria.. J Bacteriol 122(3):994-1000 PMID: 1097409
